Core Viewpoint - The company, 信铭生命科技, has noted the findings from the Securities and Futures Commission regarding its shareholding distribution, indicating a significant concentration of shares among a few shareholders and a substantial increase in share price over a specified period [1][2]. Group 1: Shareholding Structure - As of December 31, 2025, twenty shareholders and their associates collectively held 1.387 billion shares, representing 18.79% of the issued shares [1] - The three major shareholders held 5.31 billion shares, accounting for 71.94% of the issued shares, leading to a total of 90.73% of the shares being held by these entities [1] - Only 684 million shares, or 9.27% of the issued shares, were held by other shareholders [1] Group 2: Share Price Movement - The closing price of the shares increased by 489% from HKD 0.019 on September 10, 2025, to HKD 0.112 on December 31, 2025 [1] - On January 12, 2026, the share price closed at HKD 0.118, reflecting a 521% increase compared to the closing price of HKD 0.019 on September 10, 2025 [1] Group 3: Compliance with Listing Rules - The company confirms that at least 25% of its issued shares were held by the public as of December 31, 2025, and on the date of the announcement, ensuring compliance with the public float requirements of the stock exchange [2]
信铭生命科技回应股权高度集中，称公司能遵守公众持股量规定